Gene Mutation Protects Against Parkinson's Disease
By Ernie Mundell HealthDay Reporter
FRIDAY, Jan. 5, 2024 -- A rare genetic mutation found in 1% of people of European descent appears to cut their odds for Parkinson's disease in half, a new study finds.
A better understanding of how this bit of DNA works might lead to better prevention and treatment of Parkinson's generally, researchers at the University of Southern California (USC) said.
“This study advances our understanding of why people might get Parkinson's and how we might develop new therapies for this devastating disease,” said senior study author Dr. Pinchas Cohen, who first discovered the gene variant back in 2016. He's a professor of gerontology, medicine and biological sciences at USC.
As the researchers explained, the gene variant arises in a "microprotein" called SHLP2 that's found within the cell's energy factories, the mitochondria.
Prior research conducted by Cohen lab found that people lucky enough to carry the variant also seemed shielded from aging-related diseases such as cancer.
They also found that levels of SHLP2 microprotein rise as the body attempts to defend itself against Parkinson's disease.
In their latest research, the USC team screened thousands of older Americans enrolled in two major study cohorts.
Comparing people of European descent who were diagnosed with Parkinson's to those without the disease, Cohen's group found that the gene variant cut the odds of getting Parkinson's by 50%.
How does it do so?
The team believes the variant shifts the SHLP2 protein's genetic code by just one letter -- enough to boost its production and make it more stable.
All of this leads to "enhanced protection" by gene carriers against any dysfunction of cellular mitochondria, according to the USC news release. Mitochondrial dysfunction has previously been linked to Parkinson's disease, the researchers noted.
These cellular connections were further confirmed in experiments conducted in human tissue samples and mice, Cohen's group noted.
This remains very early science, of course, but it "highlights the biological effects of a particular gene variant and the potential molecular mechanisms by which this mutation may reduce the risk for Parkinson’s disease,” said study lead author Su-Jeong Kim.
The findings "may guide the development of therapies and provide a roadmap for understanding other mutations found in mitochondrial microproteins," Kim, an adjunct research assistant professor of gerontology at the USC Leonard Davis School of Gerontology, said in a university news release.
The findings were published Jan. 3 in the journal Molecular Psychiatry.
Sources
- University of Southern California, news release, Jan. 3, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Texas Rancher Developed Anthrax From Butchered Lamb Meat
FRIDAY, June 7, 2024 -- Anthrax disease in humans is rare and when it does occur, it's usually during hot, dry summers. That's why the case of a Texas rancher who developed...
Could Brain 'Overgrowth' Contribute to Autism?
FRIDAY, June 7, 2024 -- Severe forms of autism could be linked to overgrowth of the brain’s outer layer that starts while a baby is in the womb, a new study finds. Toddlers...
Patient in Mexico Dies From First Known Human Infection of H5N2 Strain of Bird Flu
THURSDAY, June 6, 2024 -- A 59-year-old person in Mexico is the first human in the world known to be infected with the H5N2 strain of avian flu, and the patient died of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
